Advancing per- and polyfluoroalkyl substances (PFAS) research: an overview of ATSDR and NCEH activities and recommendations

Rachel D. Rogers; Christopher M. Reh; Patrick Breysse

doi:10.1038/s41370-021-00316-6

journal article Apr 01, 2021

Advancing per- and polyfluoroalkyl substances (PFAS) research: an overview of ATSDR and NCEH activities and recommendations

Rachel D. Rogers

Christopher M. Reh Patrick Breysse

Journal of Exposure Science & Environmental Epidemiology Vol. 31 No. 6 pp. 961-971 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/s41370-021-00316-6

Topics

No keywords indexed for this article. Browse by subject →

References

25

[1]

Kudo N, Kawashima Y. Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. J Toxicol Sci. 2003;28:49–57. https://doi.org/10.2131/jts.28.49. 10.2131/jts.28.49

[2]

Taves DR. Evidence that there are two forms of fluoride in human serum. Nature. 1968;217:1050–1. https://doi.org/10.1038/2171050b0. 10.1038/2171050b0

[3]

Perfluoroalkyl and polyfluoroalkyl substances in the environment: Terminology, classification, and origins

Robert C Buck, James Franklin, Urs Berger et al.

Integrated Environmental Assessment and Management 2011 10.1002/ieam.258

[4]

A Never-Ending Story of Per- and Polyfluoroalkyl Substances (PFASs)?

Zhanyun Wang, Jamie C. DeWitt, Christopher P. Higgins et al.

Environmental Science & Technology 2017 10.1021/acs.est.6b04806

[5]

Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings

Christopher Lau, Katherine Anitole, Colette Hodes et al.

Toxicological Sciences 2007 10.1093/toxsci/kfm128

[6]

Detection of Poly- and Perfluoroalkyl Substances (PFASs) in U.S. Drinking Water Linked to Industrial Sites, Military Fire Training Areas, and Wastewater Treatment Plants

Xindi C. Hu, David Q. Andrews, Andrew B. Lindstrom et al.

Environmental Science & Technology Letters 2016 10.1021/acs.estlett.6b00260

[7]

Agency for Toxic Substances and Disease Registry. Toxicological Profile for Perfluoroalkyls. (Draft for Public Comment). Atlanta, GA: Agency for Toxic Substances and Disease Registry; 2018.

[8]

A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects

Elsie M. Sunderland, Xindi C. Hu, Clifton Dassuncao et al.

Journal of Exposure Science & Environmental Ep... 2019 10.1038/s41370-018-0094-1

[9]

Calafat AM, Wong L-Y, Kuklenyik Z, Reidy JA, Needham LL. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect. 2007;115:1596–602. https://doi.org/10.1289/ehp.10598. 10.1289/ehp.10598

[10]

Epidemiologic Evidence on the Health Effects of Perfluorooctanoic Acid (PFOA)

Kyle Steenland, Tony Fletcher, David A. Savitz

Environmental Health Perspectives 2010 10.1289/ehp.0901827

[11]

Agency for Toxic Substances and Disease Registry. How is ATSDR involved investigating PFAS in the environment? 2019. https://www.atsdr.cdc.gov/pfas/atsdr_sites_involvement.html.

[12]

United States. Congress. House. Committee on Armed Services. National Defense Authorization Act For Fiscal Year 2018 : Report of the Committee on Armed Services, House of Representatives on H.R. 2810 Together with Dissenting Views (Including Cost Estimate of the Congressional Budget Office). Washington: U.S. Government Publishing Office; 2017.

[13]

Post GB, Gleason JA, Cooper KR. Key scientific issues in developing drinking water guidelines for perfluoroalkyl acids: contaminants of emerging concern. PLoS Biol. 2017;15:e2002855–e2002855. https://doi.org/10.1371/journal.pbio.2002855. 10.1371/journal.pbio.2002855

[14]

Hu XC, Dassuncao C, Zhang X, Grandjean P, Weihe P, Webster GM, et al. Can profiles of poly- and perfluoroalkyl substances (PFASs) in human serum provide information on major exposure sources? Environ Health. 2018;17:11 https://doi.org/10.1186/s12940-018-0355-4. 10.1186/s12940-018-0355-4

[15]

Rappazzo KM, Coffman E, Hines EP. Exposure to perfluorinated alkyl substances and health outcomes in children: a systematic review of the epidemiologic literature. Int J Environ Res Public Health. 2017;14:691 https://doi.org/10.3390/ijerph14070691. 10.3390/ijerph14070691

[16]

Guelfo JL, Marlow T, Klein DM, Savitz DA, Frickel S, Crimi M, et al. Evaluation and management strategies for per- and polyfluoroalkyl substances (PFASs) in drinking water aquifers: perspectives from impacted U.S. Northeast communities. Environ Health Perspect. 2018;126:65001 https://doi.org/10.1289/EHP2727. 10.1289/ehp2727

[17]

Cariou R, Veyrand B, Yamada A, Berrebi A, Zalko D, Durand S, et al. Perfluoroalkyl acid (PFAA) levels and profiles in breast milk, maternal and cord serum of French women and their newborns. Environ Int. 2015;84:71–81. https://doi.org/10.1016/j.envint.2015.07.014 10.1016/j.envint.2015.07.014

[18]

Worley RR, Yang X, Fisher J. Physiologically based pharmacokinetic modeling of human exposure to perfluorooctanoic acid suggests historical non drinking-water exposures are important for predicting current serum concentrations. Toxicol Appl Pharmacol. 2017;330:9–21. https://doi.org/10.1016/j.taap.2017.07.001. 10.1016/j.taap.2017.07.001

[19]

D’eon JC, Mabury SA. Is indirect exposure a significant contributor to the burden of perfluorinated acids observed in humans? Environ Sci Technol. 2011;45:7974–84. https://doi.org/10.1021/es200171y. 10.1021/es200171y

[20]

Shankar A, Xiao J, Ducatman A. Perfluorooctanoic acid and cardiovascular disease in US adults. JAMA Intern Med. 2012;172:1397–403. https://doi.org/10.1001/archinternmed.2012.3393. 10.1001/archinternmed.2012.3393

[21]

Grandjean P, Heilmann C, Weihe P, Nielsen F, Mogensen UB, Timmermann A, et al. Estimated exposures to perfluorinated compounds in infancy predict attenuated vaccine antibody concentrations at age 5-years. J Immunotoxicol. 2017;14:188–95. https://doi.org/10.1080/1547691X.2017.1360968. 10.1080/1547691x.2017.1360968

[22]

National Toxicology Program. Monograph on immunotoxicity associated with exposure to perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). Research Triangle Park, NC: National Toxicology Program; 2016. https://ntp.niehs.nih.gov/ntp/ohat/pfoa_pfos/pfoa_pfosmonograph_508.pdf.

[23]

Buekers J, Colles A, Cornelis C, Morrens B, Govarts E, Schoeters G. Socio-economic status and health: evaluation of human biomonitored chemical exposure to per- and polyfluorinated substances across status. Int J Environ Res Public Health. 2018;15:2818 https://doi.org/10.3390/ijerph15122818. 10.3390/ijerph15122818

[24]

Finch KC, Snook KR, Duke CH, Fu KW, Tse ZTH, Adhikari A, et al. Public health implications of social media use during natural disasters, environmental disasters, and other environmental concerns. Nat Hazards. 2016;83:729–60. https://doi.org/10.1007/s11069-016-2327-8. 10.1007/s11069-016-2327-8

[25]

From Crowdsourcing to Extreme Citizen Science: Participatory Research for Environmental Health

P.B. English, M.J. Richardson, C. Garzón-Galvis

Annual Review of Public Health 2018 10.1146/annurev-publhealth-040617-013702

Metrics

70

Citations

25

References

Details

Published: Apr 01, 2021
Vol/Issue: 31(6)
Pages: 961-971
License: View

Authors

R

Rachel D. Rogers

Office of the Director, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, USA

Cite This Article

Rachel D. Rogers, Christopher M. Reh, Patrick Breysse (2021). Advancing per- and polyfluoroalkyl substances (PFAS) research: an overview of ATSDR and NCEH activities and recommendations. Journal of Exposure Science & Environmental Epidemiology, 31(6), 961-971. https://doi.org/10.1038/s41370-021-00316-6

Advancing per- and polyfluoroalkyl substances (PFAS) research: an overview of ATSDR and NCEH activities and recommendations

You May Also Like